Lupron depot 11.25 MG 3MO kits
Ended Awarded Last action
- Contract number
- SPE2DR26FQU6E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,360
Award facts
- Contract value 100% obligated
- $38,360.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $38,360.34 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 15, 2026, for the supply of Lupron Depot 11.25 mg 3-month kits. This firm fixed-price delivery order, which is not set-aside, will be fulfilled from the awardee's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of January 16, 2026. The delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s existing Indefinite Delivery Contract with the DLA Troop Support Medical (valued up to $999,999,999.00 through December 2031), which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies a comprehensive range of pharmaceutical products and medical supplies to federal agencies, particularly the Defense Logistics Agency and its Medical Supply Chain supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill competitive procurement requirements for specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for Lupron Depot—a hormone treatment used in urology and oncology applications—exemplifies the company's role as a critical vendor in the federal medical procurement supply chain.
Quick answers
Who was awarded contract SPE2DR26FQU6E?
SPE2DR26FQU6E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FQU6E worth?
The government has obligated $38,360 on SPE2DR26FQU6E.
Is contract SPE2DR26FQU6E an order under another contract?
Yes. SPE2DR26FQU6E is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQU6E competed?
The extent of competition for SPE2DR26FQU6E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award